AMTX AEMETIS, INC
Industrial Organic Chemicals · Nasdaq · SEC CIK 738214 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY23.6%
TTM net income YoY64.5%
TTM EPS YoY73.5%
Revenue 3-yr CAGR10.8%
Net income 3-yr CAGR—
Margins
Gross margin21.5%
Operating margin7.2%
Net margin-12.5%
FCF margin-14.7%
EBITDA margin11.3%
Returns
ROE—
ROA-11.3%
ROIC (approx.)17.5%
Asset turnover0.90x
Leverage & solvency
Liabilities / assets200.7%
Debt / equity—
Current ratio0.07x
Interest coverage0.32x
Cash quality & payout
Operating cash flow / net income-0.49x
Accruals ratio-16.8%
Payout ratio—
Capex / revenue20.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $88.15M | $62.70M | $54.62M | $43.31M | $59.19M | $52.24M | $42.89M | $47.00M |
| Cost of revenue | $58.68M | $49.19M | $51.86M | $45.94M | $59.25M | $55.60M | $47.97M | $49.04M |
| Gross profit | $29.47M | $13.52M | $2.76M | $7.72M | -$58,000 | -$3.35M | -$5.08M | -$2.04M |
| SG&A expense | $8.62M | $7.74M | $9.09M | $10.21M | $8.45M | $7.32M | $10.47M | $11.44M |
| Operating income | $20.85M | $5.77M | -$6.33M | -$2.48M | -$8.51M | -$10.67M | -$15.55M | -$13.48M |
| Interest expense | $14.55M | $13.66M | $14.37M | $13.94M | $12.95M | $12.33M | $13.69M | $12.64M |
| Pretax income | $5.21M | -$9.37M | -$21.84M | -$16.77M | -$23.74M | -$23.92M | -$31.31M | -$28.57M |
| Income tax | $2,000 | $0 | -$131,000 | -$11.44M | $6,000 | -$529,000 | -$6.78M | -$12.37M |
| Net income | $5.21M | -$9.37M | -$21.71M | -$5.33M | -$23.75M | -$23.39M | -$24.53M | -$16.20M |
| EBITDA | $23.43M | $8.32M | -$3.80M | $111,000 | -$6.18M | -$8.32M | -$13.20M | -$11.26M |
| EPS (basic) | 0.07 | -0.13 | -0.33 | — | -0.37 | -0.41 | -0.47 | — |
| EPS (diluted) | -0.02 | -0.13 | -0.33 | — | -0.37 | -0.41 | -0.47 | — |
| Weighted avg. shares (diluted) | 72.50M | 70.89M | 66.80M | — | 63.70M | 57.68M | 52.58M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.36M | $973,000 | $4.80M | $4.89M | $5.58M | $1.65M | $499,000 | $898,000 |
| Inventory | $12.93M | $13.64M | $10.38M | $11.63M | $4.78M | $12.37M | $22.93M | $25.44M |
| Current assets | $29.13M | $32.99M | $34.69M | $26.87M | $15.55M | $20.09M | $28.49M | $44.70M |
| PP&E, net | $271.31M | $242.83M | $222.74M | $219.72M | $209.97M | $204.64M | $199.44M | $199.39M |
| Total assets | $312.00M | $289.18M | $270.33M | $259.84M | $241.12M | $240.02M | $259.84M | $259.30M |
| Current liabilities | $439.82M | $415.03M | $396.25M | $371.26M | $343.37M | $321.93M | $174.60M | $143.97M |
| Short-term debt | $376.92M | $354.18M | $342.63M | $317.87M | $286.71M | $270.61M | $119.55M | $90.53M |
| Long-term debt | $58.52M | $61.72M | $62.05M | $63.90M | $66.79M | $73.62M | $216.74M | $247.53M |
| Total debt | $435.45M | $415.89M | $404.68M | $381.76M | $353.50M | $344.23M | $336.29M | $338.06M |
| Total liabilities | $626.20M | $611.29M | $591.47M | $566.67M | $545.97M | $529.27M | $523.21M | $523.23M |
| Shareholders' equity | -$314.21M | -$322.11M | -$321.14M | -$306.83M | -$304.85M | -$289.25M | -$280.69M | -$263.93M |
| Net debt | $432.09M | $414.92M | $399.88M | $376.87M | $347.92M | $342.59M | $335.79M | $337.16M |
| Shares outstanding | 73.10M | 72.05M | — | 66.19M | 65.00M | 61.99M | 54.04M | 51.14M |
| Cash flow statement | ||||||||
| Operating cash flow | $21.95M | -$1.88M | -$10.56M | $5.77M | $3.07M | -$5.74M | $160,000 | -$12.58M |
| Capital expenditure | $20.22M | $8.54M | $6.55M | $16.56M | $4.09M | $3.52M | $1.82M | $6.78M |
| Free cash flow | $1.73M | -$10.42M | -$17.11M | -$10.79M | -$1.02M | -$9.26M | -$1.67M | -$19.36M |
| Investing cash flow | -$20.22M | -$8.54M | -$5.11M | -$16.56M | -$4.09M | -$3.11M | -$1.82M | -$3.72M |
| Financing cash flow | -$362,000 | $7.06M | $14.70M | $10.01M | $5.13M | $10.02M | $1.25M | $16.82M |
| Depreciation & amortization | $2.58M | $2.54M | $2.54M | $2.59M | $2.33M | $2.35M | $2.36M | $2.22M |
| Stock-based compensation | $1.19M | $1.12M | $1.70M | $795,000 | $1.39M | $1.43M | $2.31M | $1.39M |
Free plan shows the latest 8 periods; Pro shows all 63 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.